Serum biomarker levels for musculoskeletal disease in two- and three-year-old racing Thoroughbred horses: A prospective study of 130 horses.
Authors: Frisbie D D, Mc Ilwraith C W, Arthur R M, Blea J, Baker V A, Billinghurst R C
Journal: Equine veterinary journal
Summary
# Editorial Summary Early detection of musculoskeletal injury in young racehorses remains challenging despite its profound economic and welfare implications, prompting investigation into whether serum biomarkers could serve as predictive screening tools in this high-risk population. Researchers tracked 130 two- and three-year-old Thoroughbreds in training over a ten-month period, collecting monthly blood samples and lameness assessments whilst documenting injuries to the joints (intra-articular fragmentation), soft tissues (tendons and ligaments), bones (stress fractures) and metacarpal region. Distinct serum biomarker patterns emerged before injury occurred, with seven markers measuring cartilage turnover (GAG, C1M, 2C, CPII, Col CEQ, CS846) and bone metabolism (osteocalcin, CTX) correctly predicting injury status 73.8% of the time using pre-injury samples alone, though predictive accuracy varied with injury type. These findings suggest serum biomarkers could complement clinical assessment as an early warning system, potentially identifying at-risk horses before lameness develops and allowing preventative management adjustments—though practitioners should recognise this is a screening adjunct rather than a diagnostic tool, and integration into routine monitoring protocols requires further validation in diverse training populations.
Read the full abstract on PubMed
Practical Takeaways
- •Serum biomarker panels may help identify young racehorses at risk of musculoskeletal injury before clinical lameness appears, enabling early intervention
- •Different injury types produce distinct biomarker signatures, potentially allowing practitioners to predict injury location and type for targeted preventive management
- •Current biomarker sensitivity (73.8%) suggests utility as a supplementary screening tool alongside traditional lameness exams, not a replacement for clinical assessment
Key Findings
- •Serum biomarkers correctly classified horses as injured or uninjured 73.8% of the time based on pre-injury samples
- •Unique biomarker patterns were identified before each type of musculoskeletal injury (IAF 27%, TL 29%, SF 12%, DMD 32% of injuries)
- •Significant longitudinal changes in biomarker levels (GAG, C1, 2C, CPII, Col CEQ, CS846, OC, CTX) were associated with specific injury types
- •Study demonstrated biomarkers have potential as a screening aid for predicting musculoskeletal injury in young racehorses